View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NORMA

Contract Research Organisation for Clinical Trials

Address
Slotsmarken 11,
2970 Horshølm,
Other,
Denmark
Phone
Fax Number

NORMA conducts clinical trials, phase I–IV, for international pharmaceutical and biotech companies, through a network of subsidiaries in the Nordic and Baltic countries.

Contract research organisation for clinical trials in northern Europe

We work together as an enthusiastic and service-orientated team to deliver outstanding work. Our flexibility and professionalism have earned us recognition among our clients and is reflected in substantial repeat business.

A recent survey of customer perception among our large customers showed that ‘high quality’ and ‘flexibility’ are the primary reasons for choosing NORMA as their monitoring company. In additon, ‘project team devoted to study’ and ‘geographic reach / presence’ are important factors.

The working climate at NORMAS’s offices is positive and friendly and we strive to keep a low staff turnover.

CRO for clinical trials in various therapeutic areas

NORMA has over 90 employees, including experienced project managers, clinical research associates and clinical trials assistants. NORMA has 19 years of experience and has participated in more than 300 clinical trials across a wide range of therapeutic areas, including:

  • Cardiovascular disorders: AMI, angina pectoris, hypertension, PAD and ACS
  • CNS: depression, schizophrenia, Alzheimer’s dementia, epilepsy, MS, Parkinson’s disease and pain
  • Dermatology: psoriasis and PLE / PMLE
  • Endocrinology: diabetes, HRT, oral contraceptives and osteoporosis
  • Infection: HIV, vaccines and herpes zoster
  • Gastrointestinal disorders: ulcerative colitis, Crohn’s disease and collagenous colitis
  • Oncology: breast cancer, prostate cancer, head-and-neck, leukaemia, solid tumours and malignant melanoma
  • Immunology: arthritis and osteoarthrosis
  • Medical devices: cardiac stents, urethral catheters and suction bags

NORMA has a strong client base with 80% repeat business due to a high level of quality. NORMA has a vast and valid network of potential investigators, and is a flexible and co-operative business partner.

Contract research services for clinical trials

NORMA staff work according to client or NORMA SOPs:

  • Recruitment and evaluation of investigators
  • GCP training of investigators and site staff
  • Submissions to medicines agencies and ethics committees
  • Organisation of investigator meetings
  • Protocol writing
  • CRF design
  • Translations
  • Regular monitoring of phase I-IV trials
  • Reporting to sponsor
  • Medical monitoring
  • Outsourcing of CRAs and CTAs

Contact NORMA

NORMA covers the entire Nordic and Baltic region in northern Europe, with offices in Denmark, Finland, Norway, Sweden, Estonia and Lithuania.

All these countries follow the general EU guidelines for approval of clinical trials; however, there are additional national – or even local – guidelines to follow. The local offices work competently and efficiently according to guidelines to meet and surpass client expectations.

Truxima (rituximab) for the Treatment of Cancer

ruxima™ (rituximab) is the first biosimilar monoclonal antibody (mAb) approved for the treatment of haematological cancers, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia, and rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

NORMA Denmark

Slotsmarken 11
2970 Horshølm
Other
Denmark

NORMA Norway

Ullernchausséen 119
N-0284 Oslo
Other
Norway

NORMA Lithuania

J. Galvydzio 3, Room 108
08236 Vilnius
Other
Lithuania

NORMA Sweden

Hemvärnsgatan 15, 10 tr.
171 54 Solna
Other
Sweden

NORMA Finland

Rajatorpantie 41 C
01640 Vantaa
Other
Finland

NORMA Estonia

Betooni 9
Tartu 51014
Other
Estonia

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena